The Gastroenterology department is recognised as a leading centre of advanced paediatric gastrointestinal medicine, clinical research and teaching. We are committed to translating excellence in research and teaching into high quality patient-focused medical and nursing care, and to further understanding of the cause, development and treatment of gastro-intestinal (GI) disorders in children.
The team sees over 5,000 children with chronic and life-limiting gut conditions each year, and has pioneered leading edge treatments for previously incurable diseases, including autoimmune paediatric gut disease
The department has close links to the Paediatric Surgery department, the Dietetic and Pharmacy departments and the Immunology and Bone Marrow Transplant Unit.
The Gastroenterology Service participates in ImproveCareNow, a United States-based collaboration between 97 Paediatric GI centres internationally, 94 in the USA, two in the UK (including GOSH) and one in Qatar. The collaboration benchmarks improvement in quality and monitors clinical outcomes for children with inflammatory bowel disease.
In May 2017, 73 per cent of our registered patients were in remission, up from 46 per cent in March 2011. In real terms, this means that an additional 45 children are now well and do not need hospitalisation or steroid treatment.
Conditions we treat
- Crohn’s disease
- Chronic Intestinal Pseudo-obstruction
- Short bowel syndrome
- Inflammatory bowel disease
- Ulcerative colitis
- Failure to thrive/faltering growth
- Tufting enteropathy
- Microvillis atrophy
- Gastrointestinal failure/small bowel transplant
- Congenital gastrointestinal disorders
- Cyclical vomiting
- Hirschsprung’s disease
- Shwachman Diamond syndrome
- Gastrointestinal food allergy
- Pancreatic disorders